IN8bio 주식 가격. INAB - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
IN8bio Inc (INAB) 시세

IN8bio Inc (INAB)

0.32

-0.0015

( -0.47% )

업데이트: 00:01:06

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

가격

0.32

매수가

0.3188

매도가

0.3249

거래량

55,957

0.32 일간 변동폭 0.3492

0.217 52주 범위 2.48

market_cap

전일 종가

0.3215

개장가

0.3226

최근 거래 시간

마지막 거래 시간

00:01:06

재정 규모

US$ 18,442

VWAP

0.329567

평균 볼륨(3m)

1,169,508

발행 주식

72,483,253

배당수익률

-

주가수익률

-0.75

주당순이익(EPS)

-0.41

매출

-

순이익

-30.01M

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.in8bio.com

본부

Wilmington, Delaware, USA

설립됨

-

IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker INAB. The last closing price for IN8bio was US$0.32. Over the last year, IN8bio shares have traded in a share price range of US$ 0.217 to US$ 2.48.

IN8bio currently has 72,483,253 shares in issue. The market capitalisation of IN8bio is US$23.30 million. IN8bio has a price to earnings ratio (PE ratio) of -0.75.

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a...

IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of autologous gamma-delta T cells for newly diagnosed glioblastoma (GBM...

IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced an...

Form S-3 - Registration statement under Securities Act of 1933

Form D - Notice of Exempt Offering of Securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.0032	1.0101010101	0.3168	0.37	0.3056	340974	0.33055421	CS
4	-0.0027	-0.836690424543	0.3227	0.41	0.2621	829135	0.32028924	CS
12	-0.2	-38.4615384615	0.52	0.5566	0.217	1169508	0.38754882	CS
26	-0.7	-68.6274509804	1.02	1.74	0.217	741640	0.57053143	CS
52	-0.5433	-62.9329317734	0.8633	2.48	0.217	618624	0.89445853	CS
156	-6.62	-95.3890489914	6.94	7.25	0.217	669284	2.11256738	CS
260	-9.68	-96.8	10	10.319	0.217	609876	2.16408233	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
WORXSCWorx Corporation	US$ 2.365 (141.33%)	69M
SKKSKK Holdings Limited	US$ 10.19 (123.46%)	878.71k
SPAISafe Pro Group Inc	US$ 4.9802 (55.63%)	31.58M
CRNCCerence Inc	US$ 4.3696 (54.95%)	5.96M
CDTConduit Pharmaceuticals Inc	US$ 0.1305 (41.39%)	373.55M
PYXSPyxis Oncology Inc	US$ 2.045 (-46.47%)	6.01M
KURAKura Oncology Inc	US$ 9.995 (-37.18%)	4.37M
BLRXBioLineRx Ltd	US$ 0.36989 (-32.16%)	4.04M
SHOTWSafety Shot Inc	US$ 0.11 (-26.67%)	1,000
TMTCTMT Acquisition Corporation	US$ 4.73 (-26.55%)	7.92k
CDTConduit Pharmaceuticals Inc	US$ 0.1296 (40.41%)	373.85M
AKTSAkoustis Technologies Inc	US$ 0.0942 (8.15%)	155.39M
NVDANVIDIA Corporation	US$ 146.39 (0.34%)	109.81M
WORXSCWorx Corporation	US$ 2.3695 (141.79%)	69.02M
ELABElevai Labs Inc	US$ 0.0204 (-4.67%)	46.86M

glenn1919

glenn1919 1 월 전

INAB....................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

Awl416

Awl416 2 월 전

IN8bio Announces Pricing of $12.4 Million Private Placement

BurgerKing82

BurgerKing82 3 월 전

glenn1919

glenn1919 3 월 전

INAB...........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

TheFinalCD

TheFinalCD 3 월 전

https://x.com/MSollender/status/1831422943987167269

Monksdream

Monksdream 3 월 전

INAB new 52 week low

glenn1919

glenn1919 5 월 전

INAB....................................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 6 월 전

INAB.................................https://stockcharts.com/h-sc/ui?s=INAB
&p=W&b=5&g=0&id=p86431144783

Tyrus603

Tyrus603 7 월 전

Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.

Laster

Laster 7 월 전

Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.

Invest-in-America

Invest-in-America 7 월 전

INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!

glenn1919

glenn1919 8 월 전

INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 9 월 전

murocman

murocman 11 월 전

Surprised how much this has tanked in light of stellar data?

Murocman

murocman

murocman 11 월 전

Outstanding data and financing in place to boot!

Should move up!

Murocman

Awl416

Awl416 11 월 전

IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia

Monksdream

Monksdream 1 년 전

Monksdream

Monksdream 1 년 전

INAB new 52 week low

Monksdream

Monksdream 1 년 전

INAB new 52 week low

The Night Stalker

The Night Stalker 1 년 전

https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

The Night Stalker

The Night Stalker 1 년 전

Mr Wick

Mr Wick 2 년 전

New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.

The Night Stalker

The Night Stalker 2 년 전

MrMocha

MrMocha 2 년 전

I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!

Mr Wick

Mr Wick 2 년 전

New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.

The Night Stalker

The Night Stalker 2 년 전

The Night Stalker

The Night Stalker 2 년 전

Trons

Trons 2 년 전

Headed to $20 on cancer developments

Jess070283

Jess070283 2 년 전

Uh oh Shorts I’m trouble….

trendzone

trendzone 2 년 전

Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.

Jess070283

Jess070283 2 년 전

Loading this dip for the rip…

Invest-in-America

Invest-in-America 2 년 전

INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)

TheFinalCD

TheFinalCD 2 년 전

Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target

subslover

subslover 2 년 전

Love your scanner! :)

2020Benzo

2020Benzo 2 년 전

Did they just post same Orphan Drug news twice in a row it’s sane PR !

TheFinalCD

TheFinalCD 2 년 전

surf1944

surf1944 2 년 전

https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1

ringo1

ringo1 2 년 전

Time to take some profits

Hercules1

Hercules1 2 년 전

It hit $3.95.

$4 break is coming.

$5 quite possible today.

Hercules1

Hercules1 2 년 전

Total beast.

Next stop $4.

And then $5.

Awl416

Awl416 2 년 전

Jess070283

Jess070283 2 년 전

Malita Investments

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관